| Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or ... - UroToday |
|
|
UroToday Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. The biological rationale for this study came from the observation that bisphosphonates and statins affect bone metastasis in different ways |